Rankings
▼
Calendar
DAWN Q3 2023 Earnings — Day One Biopharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
DAWN
Day One Biopharmaceuticals, Inc.
$2B
Q3 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$99,000
Operating Income
-$51M
Net Income
-$46M
EPS (Diluted)
$-0.54
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$37M
Free Cash Flow
-$40M
Stock-Based Comp.
$10M
Balance Sheet
Total Assets
$414M
Total Liabilities
$25M
Stockholders' Equity
$390M
Cash & Equivalents
$241M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$99,000
-$165,000
+40.0%
Operating Income
-$51M
-$40M
-29.6%
Net Income
-$46M
-$38M
-22.1%
← FY 2023
All Quarters
Q4 2023 →